Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy

Gaspard d'Assignies, Anita Paisant, Edouard Bardou-Jacquet, Anne Boulic, Elise Bannier, Fabrice Lainé, Martine Ropert, Jeff Morcet, Hervé Saint-Jalmes, Yves Gandon, Gaspard d'Assignies, Anita Paisant, Edouard Bardou-Jacquet, Anne Boulic, Elise Bannier, Fabrice Lainé, Martine Ropert, Jeff Morcet, Hervé Saint-Jalmes, Yves Gandon

Abstract

Objectives: To evaluate the performance and limitations of the R2* and signal intensity ratio (SIR) methods for quantifying liver iron concentration (LIC) at 3 T.

Methods: A total of 105 patients who underwent a liver biopsy with biochemical LIC (LICb) were included prospectively. All patients underwent a 3-T MRI scan with a breath-hold multiple-echo gradient-echo sequence (mGRE). LIC calculated by 3-T SIR algorithm (LICSIR) and by R2* (LICR2*) were correlated with LICb. Sensitivity and specificity were calculated. The comparison of methods was analysed for successive classes.

Results: LICb was strongly correlated with R2* (r = 0.95, p < 0.001) and LICSIR (r = 0.92, p < 0.001). In comparison to LICb, LICR2* and LICSIR detect liver iron overload with a sensitivity/specificity of 0.96/0.93 and 0.92/0.95, respectively, and a bias ± SD of 7.6 ± 73.4 and 14.8 ± 37.6 μmol/g, respectively. LICR2* presented the lowest differences for patients with LICb values under 130 μmol/g. Above this value, LICSIR has the lowest differences.

Conclusions: At 3 T, R2* provides precise LIC quantification for lower overload but the SIR method is recommended to overcome R2* limitations in higher overload. Our software, available at www.mrquantif.org , uses both methods jointly and selects the best one.

Key points: • Liver iron can be accurately quantified by MRI at 3 T • At 3 T, R2* provides precise quantification of slight liver iron overload • At 3 T, SIR method is recommended in case of high iron overload • Slight liver iron overload present in metabolic syndrome can be depicted • Treatment can be monitored with great confidence.

Keywords: Haemochromatosis; Haemosiderosis; Iron; Liver; Magnetic resonance imaging.

References

    1. Eur J Haematol. 2006 Aug;77(2):145-9
    1. Radiology. 2004 Feb;230(2):479-84
    1. Rofo. 2015 Jun;187(6):472-9
    1. AJR Am J Roentgenol. 2008 Feb;190(2):413-7
    1. Semin Liver Dis. 2011 Aug;31(3):260-71
    1. Hepatology. 2009 Mar;49(3):1017-44
    1. Lancet. 1971 Jan 16;1(7690):100-3
    1. Magn Reson Med. 2012 Aug;68(2):543-51
    1. J Magn Reson Imaging. 2007 Mar;25(3):540-7
    1. Blood Rev. 2008 Jul;22(4):195-210
    1. Magn Reson Imaging. 2015 Jul;33(6):761-7
    1. Blood. 2009 May 14;113(20):4853-5
    1. J Cardiovasc Magn Reson. 2014 Jun 10;16:40
    1. Magn Reson Med. 2017 Nov;78(5):1839-1851
    1. Blood. 2005 Aug 15;106(4):1460-5
    1. Lancet. 2004 Jan 31;363(9406):357-62
    1. AJR Am J Roentgenol. 1999 Apr;172(4):1141-2
    1. Radiol Res Pract. 2013;2013:628150
    1. Blood. 2005 Jan 15;105(2):855-61
    1. Eur Heart J. 2001 Dec;22(23):2171-9
    1. J Hepatol. 2013 Mar;58(3):593-608
    1. Hepatology. 2011 Jul;54(1):328-43
    1. Cancer. 2017 Mar 1;123(5):751-758
    1. Abdom Radiol (NY). 2017 Jun;42(6):1713-1720

Source: PubMed

3
Subskrybuj